The White House advisory group suggested that pricing frameworks are needed for deciding the value of cancer medicines, a step that is already taken in many other countries.

from Kaiser Health News http://ift.tt/2tNMO9t

Related Posts:

0 comments:

Post a Comment

Popular Posts